842 related articles for article (PubMed ID: 33144317)
1. Key populations for early COVID-19 immunization: preliminary guidance for policy.
Ismail SJ; Zhao L; Tunis MC; Deeks SL; Quach C;
CMAJ; 2020 Nov; 192(48):E1620-E1632. PubMed ID: 33144317
[No Abstract] [Full Text] [Related]
2. [The Saga of Vaccines against Covid-19].
Saliou P
Bull Soc Pathol Exot; 2020; 113(4):185-186. PubMed ID: 33826275
[No Abstract] [Full Text] [Related]
3. Equitable global access to coronavirus disease 2019 vaccines.
Schwartz JL
BMJ; 2020 Dec; 371():m4735. PubMed ID: 33323384
[No Abstract] [Full Text] [Related]
4. Audio Interview: An International Look at Covid-19.
Rubin EJ; Baden LR; Nottage K; O'Connell J; Wong G; Morrissey S
N Engl J Med; 2021 Jan; 384(3):e19. PubMed ID: 33471986
[No Abstract] [Full Text] [Related]
5. [The vaccines are here: Are we ready?].
Ruiz F; Fernández-Niño J
Biomedica; 2021 Mar; 41(1):5-7. PubMed ID: 33761184
[No Abstract] [Full Text] [Related]
6. Public health experts are learning from Canada's anti-mask protests.
Hapuhennedige S
CMAJ; 2020 Oct; 192(42):E1274-E1275. PubMed ID: 33077526
[No Abstract] [Full Text] [Related]
7. Can COVID-19 vaccines stop the pandemic?
Lau CS
Hong Kong Med J; 2021 Apr; 27(2):84-85. PubMed ID: 33879622
[No Abstract] [Full Text] [Related]
8. Lessons from the United Kingdom's COVID-19 vaccination strategy.
Harnden A; Earnshaw A
Med J Aust; 2021 May; 214(9):417-419. PubMed ID: 33893643
[No Abstract] [Full Text] [Related]
9. Restoring confidence in vaccines in the COVID-19 era.
Verger P; Dubé E
Expert Rev Vaccines; 2020 Nov; 19(11):991-993. PubMed ID: 32940574
[No Abstract] [Full Text] [Related]
10. A Reserve System for the Equitable Allocation of a Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine.
Makhoul AT; Drolet BC
Chest; 2021 Mar; 159(3):1292-1293. PubMed ID: 33453180
[No Abstract] [Full Text] [Related]
11. Public opinion on global rollout of COVID-19 vaccines.
Clarke PM; Roope LSJ; Loewen PJ; Bonnefon JF; Melegaro A; Friedman J; Violato M; Barnett A; Duch R
Nat Med; 2021 Jun; 27(6):935-936. PubMed ID: 33785911
[No Abstract] [Full Text] [Related]
12. Venezuela is collapsing without COVID-19 vaccines.
Loyo ESL; González MJ; Esparza J
Lancet; 2021 May; 397(10287):1806. PubMed ID: 33992140
[No Abstract] [Full Text] [Related]
13. Boosting the nation against covid-19: are the vaccination targets feasible?
Osama T; Hodes S; Razai MS; Majeed A
BMJ; 2021 Dec; 375():n3094. PubMed ID: 34911679
[No Abstract] [Full Text] [Related]
14. Early rate reductions of SARS-CoV-2 infection and COVID-19 in BNT162b2 vaccine recipients.
Amit S; Regev-Yochay G; Afek A; Kreiss Y; Leshem E
Lancet; 2021 Mar; 397(10277):875-877. PubMed ID: 33610193
[No Abstract] [Full Text] [Related]
15. Seeking to address issues with COVID-19 vaccines in Japan and to resolve global problems with vaccination programmes.
Inoue K; Ohira Y; Kawano N; Takeshita H; Hashioka S
Int Marit Health; 2021; 72(2):142. PubMed ID: 34212355
[No Abstract] [Full Text] [Related]
16. Severe mental illness: reassessing COVID-19 vaccine priorities.
Siva N
Lancet; 2021 Feb; 397(10275):657. PubMed ID: 33610199
[No Abstract] [Full Text] [Related]
17. SARS-CoV-2 Vaccines.
Creech CB; Walker SC; Samuels RJ
JAMA; 2021 Apr; 325(13):1318-1320. PubMed ID: 33635317
[No Abstract] [Full Text] [Related]
18. Audio Interview: Covid-19 in South Africa and a New SARS-CoV-2 Variant.
Rubin EJ; Baden LR; Abdool Karim SS; Morrissey S
N Engl J Med; 2021 Jan; 384(2):e14. PubMed ID: 33497556
[No Abstract] [Full Text] [Related]
19. An exceptional vaccination policy in exceptional circumstances.
The Lancet Infectious Diseases
Lancet Infect Dis; 2021 Feb; 21(2):149. PubMed ID: 33460564
[No Abstract] [Full Text] [Related]
20. Key steps in our journey to a COVID-19 vaccine program.
Blyth CC; Flanagan KL; Gibbs RA; Crawford NW; Cheng AC
Med J Aust; 2021 Apr; 214(6):249-251.e1. PubMed ID: 33745153
[No Abstract] [Full Text] [Related]
[Next] [New Search]
